Back to top
more

Alger Health Sciences Fund Class A: (MF: AHSAX)

(NASDAQ Mutual Funds) As of Apr 18, 2024 08:00 PM ET

$20.65 USD

-0.19 (-0.91%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

5-Strong Sell of 5         5

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2024

Total Return %* Percentile Rank Objective
YTD 9.28 28
3 months 9.28 28
6 months 17.31 38
1 Year 10.47 85
3 Year -2.82 93
5 Year 4.62 88
10 Year 9.11 65

* Annual for three years and beyond.

Zacks Premium Research for AHSAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Sell 5
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 9.76
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 3/31/2024 65.34
% Turnover 3/31/2024 305.60

Risk

3 Year 5 Year 10 Year
Beta 0.72 0.68 0.82
Alpha -10.28 -4.99 -0.61
R Squared 0.46 0.45 0.43
Std. Dev. 18.63 18.54 18.96
Sharpe -0.20 0.23 3.00

Sector / Country Weightings

As of 3/31/2024 % of Portfolio
Health 61.97
Finance 14.18
Services 7.73
Retail Trade 6.69
Other 6.03
Technology 2.38
Industrial Cyclical 1.02

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2024)
% of Portfolio Value (Mil$)
AMGEN INC 5.51 6.18
VERTEX PHARMACEUTICALS IN 5.31 5.96
REGENERON PHARMACEUTICALS 5.22 5.86
STRYKER CORP 5.20 5.84
ELI LILLY & CO 5.09 5.71
BOSTON SCIENTIFIC CORP 5.06 5.67
IMPULSE DYNAMICS NV 4.81 5.40
INTUITIVE SURGICAL INC 4.20 4.72
UNITEDHEALTH GROUP INC 4.14 4.64

Stock Holding % of Net Assets

As Of 1/31/2024
Total Issues 46
Avg. P/E 30.99
Avg. P/Book 5.79
Avg. EPS Growth 13.64
Avg. Market Value (Mil $) 125,756

Allocation

% of Portfolio
Large Growth 11.12
Large Value 0.00
Small Growth 28.22
Small Value 0.00
Foreign Stock 5.72
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00